Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
142 studies found for:    "Anal cancer"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Pembrolizumab in Refractory Metastatic Anal Cancer
Condition: Anal Cancer
Intervention: Drug: Pembrolizumab
2 Recruiting Shared Decision Making With Anal Cancer Patients on Radiation Dose
Condition: Anal Cancer
Interventions: Radiation: 2.15 gray and 1.8 gray. Max. 6 weeks.;   Radiation: 2.15 gray and 1.8 gray. Max. 5 weeks.
3 Completed Anal Cancer Screening Study
Condition: Anal Cancer
Intervention:
4 Unknown  Radiation Therapy, Cisplatin, Fluorouracil, and Cetuximab in Treating Patients With Locally Advanced Anal Cancer
Condition: Anal Cancer
Interventions: Biological: cetuximab;   Drug: cisplatin;   Drug: fluorouracil;   Other: laboratory biomarker analysis;   Radiation: radiation therapy
5 Terminated Radiation Therapy, Mitomycin, and Either Fluorouracil or Cisplatin in Treating Patients With Locally Advanced Anal Cancer
Condition: Anal Cancer
Interventions: Drug: cisplatin;   Drug: fluorouracil;   Drug: mitomycin C;   Radiation: radiation therapy
6 Completed Assessing Drivers and Barriers to Follow-Up Screening for Anal Cancer in Men Who Have Sex With Men
Condition: Anal Cancer
Intervention:
7 Recruiting Anal Cancer Radiotherapy Study
Condition: Anal Cancer
Intervention:
8 Completed Radiation Therapy Plus Fluorouracil With or Without Additional Chemotherapy in Treating Patients With Primary Anal Cancer
Condition: Anal Cancer
Interventions: Drug: cisplatin;   Drug: fluorouracil;   Drug: mitomycin C;   Radiation: radiation therapy
9 Recruiting Individual Following in Anal Cancer With PET/CT
Condition: Anal Cancer
Intervention: Other: anal cancer
10 Active, not recruiting A Phase I/II Evaluation of ADXS11-001, Mitomycin, 5-fluorouracil (5-FU) and IMRT for Anal Cancer
Condition: Anal Cancer
Intervention: Biological: Advaxis
11 Recruiting Quality of Life in Patients With Anal Cancer
Condition: Anal Cancer
Intervention:
12 Not yet recruiting A Phase I Study of Photodynamic Therapy (PDT) for High-grade Anal Dysplasia and Microinvasive Anal Cancer
Condition: Anal Cancer
Intervention: Drug: Gliolan
13 Unknown  Predictive Value of FMISO-PET, FDG-PET-CT, DWI-MRI and DCE-MRI Scans for Patients With Anal Cancer Receiving Radiotherapy +/- Chemotherapy
Condition: Anal Cancer
Intervention: Other: FMISO-PET, FDG-PET-CT and Magnetic Resonance Imaging (MRI)
14 Completed
Has Results
Combined Modality Therapy for Patients With With HIV and Stage I, Stage II, or Stage III Anal Cancer
Condition: Anal Cancer
Interventions: Biological: cetuximab;   Drug: cisplatin;   Drug: fluorouracil;   Radiation: radiation therapy
15 Active, not recruiting
Has Results
Cetuximab, Cisplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Anal Cancer
Condition: Anal Cancer
Interventions: Biological: cetuximab;   Drug: cisplatin;   Drug: fluorouracil;   Radiation: radiotherapy
16 Not yet recruiting Functional Outcomes Following Anal Cancer Treatment
Condition: Anal Cancer
Intervention:
17 Completed SGN-00101 in Preventing Anal Cancer in Patients With HIV Who Have Anal Neoplasia
Condition: Anal Cancer
Intervention: Biological: HspE7
18 Recruiting Dose Escalation Trial of Endoluminal High-Dose-Rate Brachytherapy With Concurrent Chemotherapy for Rectal or Anal Cancer in Patients With Recurrent Disease or Undergoing Non-Operative Management
Condition: Rectal or Anal Cancer
Interventions: Radiation: endorectal brachytherapy;   Drug: concurrent capecitabine or 5-FU;   Behavioral: Questionnaires
19 Withdrawn A Prospective, Open-Label, Multi-center Comparison of Lymphoseek Identified Lymph Nodes and Clinically Identified Lymph Nodes of Subjects With Known Cancer of the Anus
Condition: Anal Cancer
Intervention: Drug: Lymphoseek
20 Completed Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer
Condition: Anal Cancer
Interventions: Drug: cisplatin;   Drug: fluorouracil;   Drug: mitomycin C;   Radiation: radiation therapy

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.